Experience & Technical Expertise
Managing Partner & CEO
Dr Horst-H. Müther is Managing Partner and CEO of the company and advises clients in the field of medicine and health care. Together with the Hering Schuppener Group, in 2001 he established the company (trading as GCI Healthcare Unternehmensberatung für Kommunikation GmbH at the time).
Prior to this, Dr Horst-H. Müther was responsible for advising national and international customers in the field of strategic communications, marketing, PR and lobbying in his role as Practice Leader and Managing Director at Burson-Marsteller. Before this, he made a decisive contribution within the Marketing department of drugs manufacturer GlaxoSmithKline to establish a subsidiary in the field of medical education.
Dr Horst-H. Müther studied biology in Würzburg and Hamburg and was engaged as a scientific assistant at the Heinrich Pette Institute for Experimental Virology and Immunology in Hamburg (HPI).
Tel. +49 40 368075-11 // Mob. +49 172 4257055
Katharina Tolkmitt is Managing Partner at GCI Health. She advises medical and pharmaceutical clients as well as medical technology companies in all aspects of strategic healthcare communications. Her main areas of focus include: editorial support for scientific symposia and expert meetings as well as medical writing.
Prior to joining GCI Health in 2001, she was a medical editor at Bertelsmann Springer Science and Business Media and responsible for the content and strategic development of medical journals, e.g. in the field of immunology and health economy.
Katharina Tolkmitt holds a diploma in biology from the University of Hamburg. She speaks German, English and Russian.
Tel. +49 40 368075-17 // Mob. +49 170 7996272
Dr. Stephanie Schruhl
Dr Stephanie Schruhl is Director at GCI Health. She works for clients in the field of medicine (Rx) and healthcare.
Her focus is on strategic communication for complex medical diseases and new therapies, awareness as well as medical and scientific communication. Her experience covers projects in immunology, dermatology, rare diseases and oncology as well as respiratory diseases and drug development (directed evolution, protein design).
She started her professional career in 2015 as a trainee at GCI Health.
Dr. Stephanie Schruhl studied Molecular Life Science (B.Sc. and M.Sc.) in Hamburg. She received her PhD in chemistry from the International Max Planck Research School for Ultrafast Imaging and Structural Dynamics and the University of Hamburg. In addition to her scientific education, she completed the distance learning course “Public Relations” at the Freie Journalisten Schule with the degree “PR-Referent” (final thesis on healthcare topics in a web context between the German Drug Advertising Act and social media).
Tel. +49 40 368075-24 // Mob. +49 151 12515718